Table 3.
Compound | Structure | SARS-CoV-2 Mpro | SARS-CoV-2 PLpro |
---|---|---|---|
3a | 23.39% | n.i. | |
3ea | 23.70% | n.i. | |
Nirmaltrevir | 0.003 ± 0.0004 μM a | - |
Notes: % of inhibition of the enzymatic activity at 20 μM; a IC50 was determined for Nirmaltrevir; IC50 value includes standard deviation from two independent experiments, each performed in triplicate; n.i. = no inhibition.